BCR and chronic myelogenous leukemia, BCR-ABL1 positive: Initially interaction was determined with CaMELS [38], a sequence-based method that can be used to predict the propensity of interaction of a protein with CaM and CML proteins as well as identification of the CaM or CML binding sites on these proteins.